Potential of Biocellulose Carrier Impregnated with Essential Oils to Fight Against Biofilms Formed on Hydroxyapatite.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 02 2019
Historique:
received: 18 06 2018
accepted: 10 12 2018
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 26 8 2020
Statut: epublish

Résumé

In this research, bacterial cellulose (BC), one of the most promising biopolymers of the recent years, was saturated with thyme, eucalyptus and clove essential oils (EOs) and applied against staphylococcal and pseudomonal biofilms formed on hydroxyapatite (HA). BC dressings were thoroughly analyzed with regard to their physical properties. Moreover, the exact composition and ability of particular EO molecules to adhere to HA was assessed. Additionally, cytotoxicity of oil-containing, cellulose-based dressings towards osteoblasts and fibroblasts as well as their impact on reactive oxygen species (ROS) production by macrophages was assessed. The results revealed the high ability of BC dressings to absorb and subsequently release EOs from within their microstructure; the highest number of compounds able to adhere to HA was found in the thyme EO. The eucalyptus EO displayed low, while thyme and clove EOs displayed high cytotoxicity towards fibroblast and osteoblast cell lines. The clove EO displayed the highest eradication ability toward staphylococcal, while the thyme EO against pseudomonal biofilm. Taken together, the results obtained indicate the suitability of EO-saturated BC dressings to eradicate pseudomonal and staphylococcal biofilm on HA surface and moreover, to not trigger reactive oxygen species production by immune system effector cells. However, due to cytotoxic effects of thyme and clove EOs towards cell lines in vitro, the eucalyptus EO-saturated BC dressing is of highest potential to be further applied.

Identifiants

pubmed: 30718663
doi: 10.1038/s41598-018-37628-x
pii: 10.1038/s41598-018-37628-x
pmc: PMC6362291
doi:

Substances chimiques

Anti-Bacterial Agents 0
Oils, Volatile 0
Polysaccharides, Bacterial 0
Cellulose 9004-34-6
Durapatite 91D9GV0Z28

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1256

Références

Biomacromolecules. 2018 May 14;19(5):1528-1538
pubmed: 29579391
Biotechnol Rep (Amst). 2017 Jul 06;15:84-91
pubmed: 28736723
Biomaterials. 2003 Jan;24(1):181-94
pubmed: 12417192
Appl Microbiol Biotechnol. 2017 Nov;101(22):8115-8127
pubmed: 28965208
Skin Pharmacol Physiol. 2018;31(1):28-58
pubmed: 29262416
Carbohydr Polym. 2017 Feb 10;157:371-379
pubmed: 27987940
Int J Pharm. 2014 Aug 25;471(1-2):45-55
pubmed: 24792978
J Oral Maxillofac Surg. 2013 Jun;71(6):1010-6
pubmed: 23489958
Drugs. 2000 Jun;59(6):1223-32
pubmed: 10882159
J Med Chem. 2017 Mar 23;60(6):2326-2343
pubmed: 28121436
PLoS One. 2016 May 11;11(5):e0155139
pubmed: 27167126
Pharmaceuticals (Basel). 2013 Nov 25;6(12):1451-74
pubmed: 24287491
Skin Pharmacol Physiol. 2010;23(5):244-58
pubmed: 20484966
Burns. 2017 Mar;43(2):310-317
pubmed: 28341256
Eur J Immunol. 2010 Nov;40(11):3150-60
pubmed: 20957750
Microorganisms. 2017 Apr 01;5(2):
pubmed: 28368320
Evid Based Complement Alternat Med. 2015;2015:397821
pubmed: 25722735
Microb Drug Resist. 2018 Nov;24(9):1368-1375
pubmed: 29708847
Evid Based Complement Alternat Med. 2016;2016:3012462
pubmed: 28090211
J Oral Maxillofac Surg. 2015 Mar;73(3):451-64
pubmed: 25544303
Microsc Microanal. 2015 Aug;21(4):805-25
pubmed: 26169717
Int J Biol Macromol. 2017 Nov;104(Pt A):97-106
pubmed: 28587970
Med Sci (Basel). 2018 Jan 18;6(1):
pubmed: 30720776
J Pharm Anal. 2016 Apr;6(2):71-79
pubmed: 29403965
Bioresour Technol. 2009 Apr;100(8):2404-10
pubmed: 19114303
Forsch Komplementmed. 2009 Apr;16(2):79-90
pubmed: 19420953
PLoS One. 2017 Jan 11;12(1):e0169565
pubmed: 28076372
Biomaterials. 2006 Jan;27(2):145-51
pubmed: 16099034
J Microbiol Methods. 2017 Dec;143:6-12
pubmed: 28962915
J Wound Care. 2011 Nov;20(11):534, 536-9
pubmed: 22240848
Appl Microbiol Biotechnol. 2018 Sep;102(17):7417-7428
pubmed: 29982923
J Craniomaxillofac Surg. 2015 Jul;43(6):863-9
pubmed: 26027867
Int J Food Microbiol. 2004 Aug 1;94(3):223-53
pubmed: 15246235
Appl Microbiol Biotechnol. 2018 Aug;102(16):6885-6898
pubmed: 29926141

Auteurs

Adam Junka (A)

Department of Pharmaceutical Microbiology and Parasitology, Wrocław Medical University, Borowska 211A, 50-556, Wrocław, Poland.

Anna Żywicka (A)

Department of Immunology, Microbiology and Physiological Chemistry, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology, Szczecin, Piastów 45, 70-311, Szczecin, Poland.

Grzegorz Chodaczek (G)

Laboratory of Confocal Microscopy, Polish Center for Technology Development PORT, Stablowicka 147, 54-066, Wrocław, Poland.

Mariusz Dziadas (M)

Faculty of Chemistry, University of Wroclaw, Joliot-Curie 14, 50-353, Wrocław, Poland.

Joanna Czajkowska (J)

Laboratory of Microbiology, Polish Center for Technology Development PORT, Stabłowicka 147, 54-066, Wrocław, Poland.

Anna Duda-Madej (A)

Department of Medical Microbiology, Wroclaw Medical University, Chałubińskiego 4, 50-534, Wrocław, Poland.

Marzenna Bartoszewicz (M)

Department of Pharmaceutical Microbiology and Parasitology, Wrocław Medical University, Borowska 211A, 50-556, Wrocław, Poland.

Katarzyna Mikołajewicz (K)

Laboratory of Confocal Microscopy, Polish Center for Technology Development PORT, Stablowicka 147, 54-066, Wrocław, Poland.

Grzegorz Krasowski (G)

Nutrikon, KCZ Surgical Ward, Krakowska 32A, 46-020, Opole, Poland.

Patrycja Szymczyk (P)

Centre for Advanced Manufacturing Technologies (CAMT/FPC), Faculty of Mechanical Engineering, Wrocław University of Science and Technology, Łukasiewicza 5, 50-371, Wrocław, Poland.

Karol Fijałkowski (K)

Department of Immunology, Microbiology and Physiological Chemistry, Faculty of Biotechnology and Animal Husbandry, West Pomeranian University of Technology, Szczecin, Piastów 45, 70-311, Szczecin, Poland. karol.fijalkowski@zut.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH